X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13954) 13954
Magazine Article (61) 61
Book Chapter (37) 37
Book Review (14) 14
Publication (9) 9
Book / eBook (4) 4
Dissertation (3) 3
Reference (3) 3
Conference Proceeding (2) 2
Web Resource (2) 2
Newsletter (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12386) 12386
fibrinolytic agents - administration & dosage (7209) 7209
male (7005) 7005
fibrinolytic agents - therapeutic use (6706) 6706
female (6232) 6232
middle aged (4759) 4759
aged (4580) 4580
treatment outcome (3942) 3942
fibrinolytic agents - adverse effects (2833) 2833
peripheral vascular disease (2662) 2662
adult (2598) 2598
time factors (2446) 2446
animals (2379) 2379
thrombolytic therapy (2378) 2378
tissue plasminogen activator - administration & dosage (2368) 2368
stroke (2320) 2320
thrombolysis (2194) 2194
stroke - drug therapy (2063) 2063
tissue plasminogen activator - therapeutic use (2043) 2043
risk factors (2039) 2039
aged, 80 and over (1963) 1963
clinical neurology (1739) 1739
cardiac & cardiovascular systems (1721) 1721
thrombolytic therapy - methods (1689) 1689
fibrinolytic agents - pharmacology (1648) 1648
retrospective studies (1519) 1519
therapy (1444) 1444
myocardial infarction - drug therapy (1433) 1433
hematology (1393) 1393
thrombosis (1276) 1276
surgery (1263) 1263
tissue plasminogen activator (1206) 1206
anticoagulants - therapeutic use (1167) 1167
care and treatment (1119) 1119
brain ischemia - drug therapy (1075) 1075
anticoagulants - administration & dosage (1063) 1063
mortality (1024) 1024
prospective studies (1010) 1010
acute ischemic-stroke (1005) 1005
drug therapy, combination (989) 989
tissue-plasminogen activator (960) 960
management (959) 959
anticoagulants (952) 952
medicine, general & internal (944) 944
pharmacology & pharmacy (940) 940
acute disease (921) 921
thrombosis - drug therapy (915) 915
infusions, intravenous (912) 912
neurosciences (905) 905
heparin - administration & dosage (885) 885
thrombolytic therapy - adverse effects (885) 885
ischemia (869) 869
dose-response relationship, drug (846) 846
rats (844) 844
follow-up studies (828) 828
tissue plasminogen activator - adverse effects (827) 827
platelet aggregation inhibitors - therapeutic use (817) 817
alteplase (808) 808
drug therapy (795) 795
medicine & public health (792) 792
aspirin (788) 788
heparin - therapeutic use (782) 782
hemorrhage - chemically induced (780) 780
neurology (777) 777
prevention (774) 774
heparin (767) 767
risk (751) 751
administration, oral (743) 743
trial (743) 743
abridged index medicus (736) 736
risk assessment (707) 707
analysis (697) 697
injections, intravenous (688) 688
aspirin - administration & dosage (676) 676
acute myocardial-infarction (673) 673
fibrinolysis (673) 673
randomized controlled trials as topic (659) 659
platelet aggregation inhibitors - administration & dosage (654) 654
drug administration schedule (638) 638
thrombosis - prevention & control (636) 636
disease models, animal (614) 614
cardiovascular (610) 610
health aspects (609) 609
aspirin - therapeutic use (608) 608
myocardial infarction - therapy (597) 597
recombinant proteins - therapeutic use (597) 597
thromboembolism (597) 597
clinical trials as topic (595) 595
anticoagulants - adverse effects (578) 578
stroke - diagnosis (578) 578
streptokinase - administration & dosage (577) 577
molecular-weight heparin (576) 576
stroke - etiology (574) 574
prognosis (570) 570
recombinant proteins - administration & dosage (563) 563
heart attacks (560) 560
hemorrhage (560) 560
tomography, x-ray computed (558) 558
cardiology (552) 552
stroke - therapy (546) 546
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12755) 12755
German (442) 442
French (246) 246
Russian (227) 227
Japanese (165) 165
Spanish (162) 162
Italian (119) 119
Norwegian (59) 59
Danish (55) 55
Polish (55) 55
Chinese (54) 54
Swedish (36) 36
Portuguese (35) 35
Hungarian (32) 32
Czech (17) 17
Dutch (15) 15
Turkish (15) 15
Finnish (11) 11
Lithuanian (8) 8
Hebrew (7) 7
Romanian (7) 7
Ukrainian (7) 7
Serbian (6) 6
Bulgarian (5) 5
Croatian (3) 3
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2008, Volume 372, Issue 9632, pp. 31 - 39
Summary Background The risk of venous thromboembolism is high after total hip arthroplasty and could persist after hospital discharge. Our aim was to compare... 
Internal Medicine | WEIGHT HEPARIN-PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | PLACEBO | FACTOR-XA INHIBITOR | ORTHOPEDIC-SURGERY | KNEE REPLACEMENT | BAY-59-7939 | THROMBOSIS | PROLONGED THROMBOPROPHYLAXIS | TIME-COURSE | DALTEPARIN | Thiophenes - therapeutic use | Double-Blind Method | Drug Administration Schedule | Thiophenes - adverse effects | Humans | Middle Aged | Morpholines - administration & dosage | Arthroplasty, Replacement, Hip | Male | Thiophenes - administration & dosage | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Fibrinolytic Agents - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Enoxaparin - administration & dosage | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Fibrinolytic Agents - administration & dosage | Morpholines - adverse effects | Morpholines - therapeutic use | Health care | Medical imaging | Hospitals | Protease inhibitors | Surgery | Tomography | Joint surgery | Drug therapy | Patients | Veins & arteries | Index Medicus | Abridged Index Medicus | Thiophenes/administration & dosage/adverse effects/therapeutic use | use | Arthroplasty | Replacement | Venous Thromboembolism/prevention & control | Morpholines/administration & dosage/adverse effects/therapeutic use | Kirurgi | Hip | 80 and over | Enoxaparin/administration & dosage/adverse effects/therapeutic use | Fibrinolytic Agents/administration & dosage/adverse effects/therapeutic
Journal Article
Journal Article
Journal Article
Annals of internal medicine, ISSN 0003-4819, 2011, Volume 154, Issue 1, pp. 1 - 11
Background: Warfarin reduces the risk for ischemic stroke in patients with atrial fibrillation (AF) but increases the risk for hemorrhage. Dabigatran is a... 
POPULATION | MEDICINE, GENERAL & INTERNAL | THERAPY | MANAGEMENT | RISK-FACTOR | MYOCARDIAL-INFARCTION | ORAL ANTICOAGULATION | HEMORRHAGIC COMPLICATIONS | CLINICAL CLASSIFICATION SCHEMES | NATIONAL REGISTRY | ASPIRIN | Myocardial Infarction - chemically induced | Markov Chains | Anticoagulants - administration & dosage | Humans | Anticoagulants - economics | Warfarin - adverse effects | Warfarin - economics | Benzimidazoles - economics | Dabigatran | Warfarin - administration & dosage | Fibrinolytic Agents - adverse effects | Ischemic Attack, Transient - prevention & control | Benzimidazoles - administration & dosage | beta-Alanine - economics | Sensitivity and Specificity | Aged, 80 and over | Benzimidazoles - adverse effects | beta-Alanine - analogs & derivatives | Quality-Adjusted Life Years | Stroke - prevention & control | beta-Alanine - adverse effects | Risk Factors | Atrial Fibrillation - complications | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Fibrinolytic Agents - economics | Cost-Benefit Analysis | Intracranial Hemorrhages - chemically induced | Aged | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Stroke (Disease) | Prevention | Complications and side effects | Warfarin | Atrial fibrillation | Dosage and administration | Research | Drug therapy | Risk factors
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 8, pp. 699 - 708
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 04/2010, Volume 103, Issue 4, pp. 815 - 825
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9834, pp. 2352 - 2363
Journal Article